Osamu Shibahara Selected Research

benzotriazole

1/2019	Dual conformation of the ligand induces the partial agonistic activity of retinoid X receptor α (RXRα).
1/2017	Synthesis of 11C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [11C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Osamu Shibahara Research Topics

Disease

2	Central Nervous System Diseases (CNS Diseases) 01/2019 - 01/2017
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2019
1	Crohn Disease (Crohn's Disease) 01/2019
1	Colitis 01/2019
1	Ulcerative Colitis 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019

Drug/Important Bio-Agent (IBA)

4	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2019 - 01/2017
3	1- (3,5,5,8,8- pentamethyl- 5,6,7,8- tetrahydro- 2- naphthyl)- 1H- benzotriazole- 5- carboxylic acidIBA 01/2019 - 01/2017
2	Carboxylic AcidsIBA 01/2019 - 01/2017
2	benzotriazoleIBA 01/2019 - 01/2017
2	Bexarotene (LGD1069)FDA Link 01/2019 - 01/2017
1	Docosahexaenoic AcidsIBA 01/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	Therapeutic UsesIBA 01/2017
1	Benzoic Acid (Potassium Benzoate)FDA Link 01/2017